Mutual Pharmaceutical has received FDA approval of its Abbreviated New Drug Application (ANDA) for Butalbital 50mg/Acetaminophen 325mg/Caffeine 40mg tablets.

Mutual's Butalbital 50mg/Acetaminophen 325mg/Caffeine 40mg tablets are AB-rated to Fioricet tablets, manufactured and distributed by Novartis.

Other recent approvals and product launches from URL/Mutual include Felodipine 2.5mg, 5mg and 10mg ER tablets (AB-rated to Plendil ER, Astra Zeneca), Clonidine HCl 0.1mg, 0.2mg and 0.3mg tablets (AB-rated to Catapres, Boehringer Ingelheim), Gabapentin 100mg, 300mg and 400mg capsules (AB-rated to Neurontin, Pfizer) and Folic Acid 1mg tablets (AB-rated to Folic Acid, Watson).

United Research Laboratories/Mutual Pharmaceutical Company, a privately-held company headquartered in Philadelphia, is engaged in the research, development, manufacturing and commercialization of generic and branded pharmaceutical products.